↓ Skip to main content

Estimating the clinical cost of drug development for orphan versus non-orphan drugs

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
policy
1 policy source
twitter
39 X users
googleplus
1 Google+ user

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
258 Mendeley